Bausch Health Companies Inc.

NYSE:BHC

Pharmaceutical Preparations·QUEBEC, A8

Bausch Health Companies Inc. is a global, diversified Canadian pharmaceutical company.

CEO

Appio Thomas

CFO

Charhon Jean-Jacques

Summary Financials

Revenue

$8.8B

+7.8% YoY

FY 2025

Adj. EBITDA

$2.2B

25.4% margin

FY 2025

Net Income

-$592.0M

-6.8% margin

FY 2025

EPS (Diluted)

-$1.62

FY 2025

Stock Price

$5.06

+0.6%

2026-03-23

52W Range

$4.25 – $8.69

P/E Ratio

-3.1x

Market Cap

$1.9B

Cash

$947.0M

FY 2025

Total Debt

$19.0B

FY 2025

Net Debt

$18.0B

FY 2025

Enterprise Value

$19.9B

Debt / EBITDA

8.1x

FY 2025

EV / EBITDA

8.9x

Employees

—

Bausch Health Companies Inc. is a global, diversified Canadian pharmaceutical company.

CEO

Appio Thomas

CFO

Charhon Jean-Jacques

Revenue

$8.8B

+7.8% YoY

FY 2025

Adj. EBITDA

$2.2B

25.4% margin

FY 2025

Net Income

-$592.0M

-6.8% margin

FY 2025

EPS (Diluted)

-$1.62

FY 2025

Stock Price

$5.06

+0.6%

2026-03-23

52W Range

$4.25 – $8.69

P/E Ratio

-3.1x

Market Cap

$1.9B

Cash

$947.0M

FY 2025

Total Debt

$19.0B

FY 2025

Net Debt

$18.0B

FY 2025

Enterprise Value

$19.9B

Debt / EBITDA

8.1x

FY 2025

EV / EBITDA

8.9x

Employees

—